DUPHAT Conference and Exhibition commenced its second day with resounding success, poised to attract an impressive crowd of more than 32,000 participants.

The exhibition features the unveiling of several remarkable new products on a global scale, and the scientific conference programme is delving deep into the intricacies of medical advancements.

The event remains a premier platform for innovation and knowledge exchange, setting the stage for impactful developments in the field of healthcare.

Approximately 95 countries are present at DUPHAT this year, fostering cross-collaboration among companies and agents. Türkiye, Poland, China, and India stand out with dedicated country pavilions, strategically introducing their esteemed products to the market.

Hosted at the World Trade Centre, this annual three-day event stands as the largest pharmaceutical gathering in the Middle East and Africa, serving as a pivotal gateway for Western and European entities to tap into the thriving regional market driven by top-notch healthcare and accessible over-the-counter medicine.

More than 1,300 companies and brands are competing to triumph the start of the new year and set a high-level of excellence that is sure to raise the standards of quality in the industry. Many are taking advantage and launching new products at DUPHAT this year hoping to make a powerful impact and technology is shown to be increasingly valuable.

The UAE has topped the Middle East and Africa in terms of the number of approved medications containing novel active substances and the speed at which drug regulatory dossiers are evaluated and approved. This accomplishment was made possible by the UAE Ministry of Health and Prevention (MoHAP) shortening the time needed to assess new medication dossiers, enabling it to approve 187 new medicines containing active ingredients throughout the study period.

DUPHAT is organised annually by INDEX Conferences and Exhibitions – a member of INDEX Holding, and is supported by Dubai Health Authority, American Society of Health-System Pharmacists, International Society for Pharmacoepidemiology, European Federation for Pharmaceutical Sciences, European Society of Clinical Pharmacy, Society of Hospital Pharmacists of Australia and the European Society of Oncology Pharmacy.